发明公开
EP1258246A2 Controlled release oxycodone compositions
失效
Oxycodonhaltige Zubereitungen mit gesteuerter Wirkstoffabgabe
- 专利标题: Controlled release oxycodone compositions
- 专利标题(中): Oxycodonhaltige Zubereitungen mit gesteuerter Wirkstoffabgabe
-
申请号: EP02008249.1申请日: 1992-11-25
-
公开(公告)号: EP1258246A2公开(公告)日: 2002-11-20
- 发明人: Oshlack, Benjamin , Chasin, Mark , Minogue, John Joseph , Kaiko, Robert Francis
- 申请人: Euro-Celtique S.A.
- 申请人地址: 122 Boulevard de la Petrusse Luxemburg LU
- 专利权人: Euro-Celtique S.A.
- 当前专利权人: Euro-Celtique S.A.
- 当前专利权人地址: 122 Boulevard de la Petrusse Luxemburg LU
- 代理机构: Maiwald Patentanwalts GmbH
- 优先权: US800549 19911127
- 主分类号: A61K31/485
- IPC分类号: A61K31/485 ; A61K9/20 ; A61K9/28
摘要:
A method for substantially reducing the range in daily dosages required to control pain in approximately 80% of patients is disclosed whereby an oral solid controlled release dosage formulation having from about 10 to about 40 mg of oxycodone or a salt thereof is administered to a patient. The formulation provides a mean maximum plasma concentration of oxycodone from about 6 to about 60 ng/ml from a mean of about 2 to about 4.5 hours after administration, and a mean minimum plasma concentration from about 3 to about 30 ng/ml from about 10 to about 14 hours after repeated "q12h" (i.e., every 12 hours) administration through steady-state conditions. Another embodiment is directed to a method for substantially reducing the range in daily dosages required to control pain in substantially all patients. The figure is a graph showing the mean plasma oxycodone concentration for a 10 mg controlled release oxycodone formulation prepared in accordance with the present invention and a study reference standard.
公开/授权文献
- EP1258246B1 Controlled release oxycodone compositions 公开/授权日:2004-03-17
信息查询
IPC分类: